Both animal models of thrombotic APS and clinical evidences, demonstrating higher serum levels of C5b-9 in patients with aPL and stroke, support a role for complement in aPL mediated thrombosis [70]. The gene discussed is FASLG; the disease is autoimmune polyendocrinopathy.